BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
227 hedge funds and large institutions have $1.39B invested in BioTelemetry, Inc. in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 64 increasing their positions, 95 reducing their positions, and 15 closing their positions.
173% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 15
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
72% more call options, than puts
Call options by funds: $23.1M | Put options by funds: $13.4M
46% more capital invested
Capital invested by funds: $952M → $1.39B (+$434M)
12% more funds holding
Funds holding: 202 → 227 (+25)
33% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 95
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$42.1M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$16M |
| 3 |
BlackRock
New York
|
+$13.5M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
+$12.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$20.5M |
| 2 |
Bank of New York Mellon
New York
|
-$10.8M |
| 3 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$10.6M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$8.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.38M |
BEAT Hedge Fund Activity: Q2 2018 in Review
227 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q2 2018, worth a combined $1.39B — up 46% from $952M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new BEAT positions and 15 closed out — a net gain of 26 holders — while 64 added to existing stakes and 95 trimmed.
The largest buyer was Invesco, adding an estimated $42.1M. The largest seller was Credit Suisse, cutting an estimated $20.5M.
- 227 institutional investors held BioTelemetry, Inc. (BEAT) as of Q2 2018, up from 202 in Q1 2018.
- Funds reported $1.39B of BioTelemetry, Inc. stock for Q2 2018, up 46% quarter-over-quarter.
- 41 funds opened new BioTelemetry, Inc. positions in Q2 2018 and 15 closed out, a net change of +26 holders.
- The largest BioTelemetry, Inc. buyer in Q2 2018 was Invesco, an estimated $42.1M added.
- The largest BioTelemetry, Inc. seller in Q2 2018 was Credit Suisse, an estimated $20.5M sold.
Based on aggregated 13F filings for Q2 2018.